287 related articles for article (PubMed ID: 31088961)
1. Inhibition of β-catenin/B cell lymphoma 9 protein-protein interaction using α-helix-mimicking sulfono-γ-AApeptide inhibitors.
Sang P; Zhang M; Shi Y; Li C; Abdulkadir S; Li Q; Ji H; Cai J
Proc Natl Acad Sci U S A; 2019 May; 116(22):10757-10762. PubMed ID: 31088961
[TBL] [Abstract][Full Text] [Related]
2. Sulfono-γ-AApeptides as Helical Mimetics: Crystal Structures and Applications.
Sang P; Shi Y; Huang B; Xue S; Odom T; Cai J
Acc Chem Res; 2020 Oct; 53(10):2425-2442. PubMed ID: 32940995
[TBL] [Abstract][Full Text] [Related]
3. α-Helix-Mimicking Sulfono-γ-AApeptide Inhibitors for p53-MDM2/MDMX Protein-Protein Interactions.
Sang P; Shi Y; Lu J; Chen L; Yang L; Borcherds W; Abdulkadir S; Li Q; Daughdrill G; Chen J; Cai J
J Med Chem; 2020 Feb; 63(3):975-986. PubMed ID: 31971801
[TBL] [Abstract][Full Text] [Related]
4. Rational Design and Synthesis of Right-Handed d-Sulfono-γ-AApeptide Helical Foldamers as Potent Inhibitors of Protein-Protein Interactions.
Sang P; Shi Y; Higbee P; Wang M; Abdulkadir S; Lu J; Daughdrill G; Chen J; Cai J
J Org Chem; 2020 Aug; 85(16):10552-10560. PubMed ID: 32700908
[TBL] [Abstract][Full Text] [Related]
5. The activity of sulfono-γ-AApeptide helical foldamers that mimic GLP-1.
Sang P; Zhou Z; Shi Y; Lee C; Amso Z; Huang D; Odom T; Nguyen-Tran VTB; Shen W; Cai J
Sci Adv; 2020 May; 6(20):eaaz4988. PubMed ID: 32440547
[TBL] [Abstract][Full Text] [Related]
6. Sulfono-γ-AApeptides as Protein Helical Domain Mimetics to Manipulate the Angiogenesis.
Xue S; Wang L; Cai J
Chembiochem; 2022 Nov; 23(22):e202200298. PubMed ID: 36006398
[TBL] [Abstract][Full Text] [Related]
7. Discovery of α-helix-mimicking sulfono-γ-AApeptides as p53-MDM2 inhibitors.
Shi Y; Sang P; Cai J
Future Med Chem; 2021 Jun; 13(12):1021-1023. PubMed ID: 33906432
[No Abstract] [Full Text] [Related]
8. Sulfono-γ-AApeptides as a new class of nonnatural helical foldamer.
Wu H; Qiao Q; Hu Y; Teng P; Gao W; Zuo X; Wojtas L; Larsen RW; Ma S; Cai J
Chemistry; 2015 Feb; 21(6):2501-7. PubMed ID: 25504756
[TBL] [Abstract][Full Text] [Related]
9. Design of triazole-stapled BCL9 α-helical peptides to target the β-catenin/B-cell CLL/lymphoma 9 (BCL9) protein-protein interaction.
Kawamoto SA; Coleska A; Ran X; Yi H; Yang CY; Wang S
J Med Chem; 2012 Feb; 55(3):1137-46. PubMed ID: 22196480
[TBL] [Abstract][Full Text] [Related]
10. Rational Design of Right-Handed Heterogeneous Peptidomimetics as Inhibitors of Protein-Protein Interactions.
Shi Y; Sang P; Lu J; Higbee P; Chen L; Yang L; Odom T; Daughdrill G; Chen J; Cai J
J Med Chem; 2020 Nov; 63(21):13187-13196. PubMed ID: 33140956
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in β-catenin/BCL9 protein-protein interaction inhibitors.
Zhang H; Bao Y; Liu C; Li J; Zhu D; Zhang Q
Future Med Chem; 2021 May; 13(10):927-940. PubMed ID: 33849283
[TBL] [Abstract][Full Text] [Related]
12. Right-Handed Helical Foldamers Consisting of De Novo d-AApeptides.
Teng P; Ma N; Cerrato DC; She F; Odom T; Wang X; Ming LJ; van der Vaart A; Wojtas L; Xu H; Cai J
J Am Chem Soc; 2017 May; 139(21):7363-7369. PubMed ID: 28480699
[TBL] [Abstract][Full Text] [Related]
13. Rational design of selective small-molecule inhibitors for β-catenin/B-cell lymphoma 9 protein-protein interactions.
Hoggard LR; Zhang Y; Zhang M; Panic V; Wisniewski JA; Ji H
J Am Chem Soc; 2015 Sep; 137(38):12249-60. PubMed ID: 26352795
[TBL] [Abstract][Full Text] [Related]
14. γ-AApeptides: Design, Structure, and Applications.
Shi Y; Teng P; Sang P; She F; Wei L; Cai J
Acc Chem Res; 2016 Mar; 49(3):428-41. PubMed ID: 26900964
[TBL] [Abstract][Full Text] [Related]
15. Helical sulfono-γ-AApeptides with predictable functions in protein recognition.
Sang P; Shi Y; Wei L; Cai J
RSC Chem Biol; 2022 Jul; 3(7):805-814. PubMed ID: 35866163
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 2-(3-(3-Carbamoylpiperidin-1-yl)phenoxy)acetic Acid Derivatives as Novel Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.
Wang Z; Zhang M; Luo W; Zhang Y; Ji H
J Med Chem; 2021 May; 64(9):5886-5904. PubMed ID: 33902288
[TBL] [Abstract][Full Text] [Related]
17. Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signaling.
Takada K; Zhu D; Bird GH; Sukhdeo K; Zhao JJ; Mani M; Lemieux M; Carrasco DE; Ryan J; Horst D; Fulciniti M; Munshi NC; Xu W; Kung AL; Shivdasani RA; Walensky LD; Carrasco DR
Sci Transl Med; 2012 Aug; 4(148):148ra117. PubMed ID: 22914623
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 1-Benzoyl 4-Phenoxypiperidines as Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.
Li Z; Zhang M; Teuscher KB; Ji H
J Med Chem; 2021 Aug; 64(15):11195-11218. PubMed ID: 34270257
[TBL] [Abstract][Full Text] [Related]
19. Helical 1:1 α/Sulfono-γ-AA Heterogeneous Peptides with Antibacterial Activity.
She F; Nimmagadda A; Teng P; Su M; Zuo X; Cai J
Biomacromolecules; 2016 May; 17(5):1854-9. PubMed ID: 27030636
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Tcf4 G13ANDE17 binding site to selectively disrupt β-catenin/T-cell factor protein-protein interactions.
Huang Z; Zhang M; Burton SD; Katsakhyan LN; Ji H
ACS Chem Biol; 2014 Jan; 9(1):193-201. PubMed ID: 24191653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
